Isthmin-1 blood test for rheumatoid arthritis activity
Part of Bones, joints & muscles, Immune system & allergy clinical trials.
This study looks at a new blood marker called Isthmin-1 to see if it can measure how active your rheumatoid arthritis is. They compare it with ultrasound images of your joints to better understand disease activity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have been diagnosed with rheumatoid arthritis using standard criteria
- You do not have other autoimmune diseases like lupus or psoriasis
- You do not have an active infection, cancer, or diabetes
- You have not had recent hand surgery, injury, or nerve problems affecting your hand use
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a specific antibody in the blood that may help diagnose or monitor rheumatoid arthritis (RA). It aims to see if this marker can distinguish RA from other conditions.
This trial measures levels of a protein called CCL-21 in the blood of people with rheumatoid arthritis, osteoarthritis, and healthy volunteers. The goal is to see if CCL-21 levels relate to disease activity and could help track inflammation.
This study looks at specific genetic differences and blood levels of immune proteins to see how they relate to rheumatoid arthritis risk and how active the disease is. It may help researchers understand who is more likely to have rheumatoid arthritis and when the condition is more active.
This trial studies a substance called triosephosphate isomerase (an enzyme) in the blood of people with rheumatoid arthritis. The goal is to see if its level is linked to how active your RA is and to any joint damage over time.
This study checks if a simple blood test (complete blood count) can help detect active rheumatoid arthritis as well as standard blood tests (CRP and ESR). It's for people already diagnosed with RA who live in Upper Egypt.
This study looks at levels of certain immune system proteins (IL-6, IL-12, IL-15, and IL-23) in the blood of people with rheumatoid arthritis. It aims to understand how these proteins relate to the disease and may help guide future treatments for better outcomes.
Hear when a new Disease Activity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.